Preparation of gellan sulfate as an artificial ligand for removal of extra domain A containing fibronectin

被引:17
|
作者
Miyamoto, K [1 ]
Asakawa, Y [1 ]
Arai, Y [1 ]
Shimizu, T [1 ]
Tokita, M [1 ]
Komai, T [1 ]
机构
[1] Mie Univ, Fac Engn, Dept Chem Mat, Tsu, Mie 5145807, Japan
关键词
extra domain A containing fibronectin; plasma fibronectin; cryogel; gellan sulfate;
D O I
10.1016/S0141-8130(01)00135-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The extra domain A containing fibronectin (EDA( + )FN) concentration in plasma of rheumatoid arthritis (RA) is abnormally higher than the normal level. We synthesized various gellan-sulfate (GS) candidates as artificial ligands for- removing EDA( + )FN from plasma. The interaction between these artificial ligands and EDA(+)FN was evaluated using affinity constants (KA), which were determined by surface plasmon resonance measurement. The KA (3.6 x 10(8) per M) of GS-25 [degree of substitution for sulfonation (DS) = 25%] with EDA( + )FN was higher than those of other molecules: GS-16 (DS = 16%) at 8.3 x 10(7) per M, and GS-35 (DS = 35%) at 1.7 x 10(8) per M. Furthermore, GSs displayed selectivity of EDA(+)FN for binding with plasma FN (KA(ED Lambda( + )FN)/KA(plasma) (FN) > 2). The removal ratio in plasma was measured by using GS-immobilized gel. Removals of 66, 11, 7.7, 6.2, 6.9, and 12% for EDA( + )FN, plasma FN, fibrinogen, albumin, immunoglobulin G (IgG) and antithrombin III from the patient-model plasma were, respectively, achieved with GS-25-immobilized gel. These results suggest that GS may be used as a selective artificial ligand for EDA( + )FN removal from plasma in RA treatment. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:381 / 385
页数:5
相关论文
共 39 条
  • [1] Novel plasma-separation dilayer gellan-gellan-sulfate adsorber for direct removal of extra domain A containing fibronectin from the blood of rheumatoid arthritis patients
    Miyamoto, K
    Sugihara, K
    Abe, Y
    Nobori, T
    Tokita, M
    Komai, T
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2002, 30 (3-4) : 197 - 204
  • [2] Adhesion of 3-carboxymethyl-cellulose-6-sulfate to extra domain A-containing fibronectin: Development of ligands for cryogel removal
    Miyamoto K.
    Shimizu M.
    Tokita M.
    Komai T.
    Journal of Artificial Organs, 2002, 5 (2) : 132 - 135
  • [3] Expression of extra domain A containing fibronectin in chronic cardiac allograft rejection
    Franz, Marcus
    Berndt, Alexander
    Gruen, Katja
    Richter, Petra
    Kosmehl, Hartwig
    Neri, Dario
    Gummert, Jan
    Figulla, Hans R.
    Brehm, Bernhard R.
    Renner, Andre
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (01): : 86 - 94
  • [4] A fibronectin isoform containing the extra domain A (EDA) increases osteoblast differentiation and function
    Sens, C.
    Kawelke, N.
    Nakchbandi, I.
    BONE, 2012, 50 : S74 - S75
  • [5] Specific interactions between cryogel components: role of extra domain A containing fibronectin in cryogelation
    Miyamoto, K
    Kodera, N
    Umekawa, H
    Furuichi, Y
    Tokita, M
    Komai, T
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2002, 30 (3-4) : 205 - 212
  • [6] The fibroblast of radicular cyst facilitate osteoclastogenesis via the autocrine of Fibronectin containing extra domain A
    Liu, Chun-yan
    Wang, Hai-Cheng
    ORAL DISEASES, 2019, 25 (04) : 1136 - 1146
  • [7] Serum extra domain B containing fibronectin (EDB FN) - a biomarker for proliferative diabetic retinopathy
    Georg, Biju
    Chen, Shali
    Chaudhary, Varun
    Gonder, John
    Chakrabarti, Subrata
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S38 - S38
  • [8] Fibronectin Containing Extra Domain a in the Plasma, but not Tissue, Exacerbates Stroke Outcome in the Comorbid Condition of Hyperlipidemia
    Dhanesha, Nirav
    Chorawala, Mehul
    Doddapattar, Prakash
    Chauhan, Anil
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [9] Involvement of the endogenous TLR-4 ligand Extra Domain A of fibronectin in collateral artery growth in mice
    De Groot, D.
    Grundmann, S.
    De Kleijn, D. P. V.
    Pasterkamp, G.
    Hoefer, I.
    EUROPEAN HEART JOURNAL, 2009, 30 : 956 - 956
  • [10] Low levels of extra domain A containing fibronectin in human atherosclerotic plaques are associated with a vulnerable plaque phenotype
    van Keulen, J. Karlijn
    de Kleijn, Dominique P.
    Nijhuis, Manon M. Oude
    Busser, Els
    Velema, Evelyn
    Fijnheer, Rob
    van der Graaf, Yolanda
    CIRCULATION, 2006, 114 (18) : 32 - 32